Sofiya Milman MD MSc
Diabetes, Lipid Metabolism
Professor of Medicine and Genetics, Albert Einstein College of Medicine
Join to View Full Profile
495 Central Park AveScarsdale, NY 10583
Phone+1 866-633-8255
Fax+1 914-721-2992
Dr. Milman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Endocrinology, Diabetes, and Metabolism, 2009 - 2011- Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 2006 - 2009
Stony Brook University Health Sciences Center School of MedicineClass of 2006
Certifications & Licensure
NY State Medical License 2010 - 2025
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Publications & Presentations
PubMed
- Identification of functional rare coding variants in IGF-1 gene in humans with exceptional longevity.Amanat Ali, Zhengdong D Zhang, Tina Gao, Sandra Aleksic, Evripidis Gavathiotis
Scientific Reports. 2025-03-25 - Tailored Approach to Designing a Digital Research Platform for Adults Aged 95 and Older: SuperAgers Family Study.Sofiya Milman, Aisha Montgomery, Nir Barzilai, Tina Gao, Kara A Wilson
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences. 2025-03-07 - Plasma proteomic characterization of motoric cognitive risk and mild cognitive impairment.Gabriela T Gomez, Sanish Sathyan, Jingsha Chen, Myriam Fornage, Pascal Schlosser
Alzheimer's & Dementia. 2025-02-01
Press Mentions
What Matters More for Longevity: Genes or Lifestyle?January 8th, 2025
Does Our Blood Hold the Secrets of Our Longevity?January 22nd, 2020
Einstein Receives $178 Million in NIH Funding in Fiscal Year 2019, Largest Annual Total in Institution’s HistoryDecember 10th, 2019- Join now to see all
Grant Support
- CH in Aging and Exceptional LongevityALBERT EINSTEIN COLLEGE OF MEDICINE2024–2029
- CH in Aging and Exceptional LongevityALBERT EINSTEIN COLLEGE OF MEDICINE2024–2029
- CH in Aging and Exceptional LongevityALBERT EINSTEIN COLLEGE OF MEDICINE2024–2029
- CH in Aging and Exceptional LongevityALBERT EINSTEIN COLLEGE OF MEDICINE2024–2029
- CH in Aging and Exceptional LongevityALBERT EINSTEIN COLLEGE OF MEDICINE2024–2029
- Multi-omics approach to frailty resilienceALBERT EINSTEIN COLLEGE OF MEDICINE2014–2029
- Multi-omics approach to frailty resilienceALBERT EINSTEIN COLLEGE OF MEDICINE2014–2029
- Multi-omics approach to frailty resilienceALBERT EINSTEIN COLLEGE OF MEDICINE2014–2029
- Multi-omics approach to frailty resilienceALBERT EINSTEIN COLLEGE OF MEDICINE2014–2029
- Development of a Growth Hormone Receptor antagonist for the delay or prevention of ADRDMOLECULAR TECHNOLOGIES LABORATORIES LLC2024–2026
- Development of a Growth Hormone Receptor antagonist for the delay or prevention of ADRDMOLECULAR TECHNOLOGIES LABORATORIES LLC2024–2026
- Development of a Growth Hormone Receptor antagonist for the delay or prevention of ADRDMOLECULAR TECHNOLOGIES LABORATORIES LLC2024–2026
- Development of a Growth Hormone Receptor antagonist for the delay or prevention of ADRDMOLECULAR TECHNOLOGIES LABORATORIES LLC2024–2026
- Somatotropic Signaling and Resilience to Aging and Alzheimer's DiseaseALBERT EINSTEIN COLLEGE OF MEDICINE2019–2025
- Somatotropic Signaling and Resilience to Aging and Alzheimer's DiseaseALBERT EINSTEIN COLLEGE OF MEDICINE2019–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
